Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31314317 | 1.00 | MEN1 (0.36) | MEN1KMT2ATDP1 | |
| SCHEMBL7258717 | 1.00 | MEN1 (0.36) | MEN1KMT2ATDP1 | |
| SCHEMBL4846634 | 0.82 | MEN1 (0.36) | MEN1KMT2ATDP1 | |
| SCHEMBL16295072 | 0.67 | MEN1 (0.62) | MEN1KMT2ATDP1 | |
| SCHEMBL693244 | 0.67 | — | — | |
| SCHEMBL396358 | 0.67 | MEN1 (0.62) | MEN1KMT2ATDP1 | |
| Perfluorocyclobutane SCHEMBL24521 | 0.67 | MEN1 (0.62) | MEN1KMT2ATDP1 | |
| SCHEMBL7260823 | 0.67 | MEN1 (0.62) | MEN1KMT2ATDP1 | |
| SCHEMBL61759 | 0.67 | MEN1 (0.62) | MEN1KMT2ATDP1 | |
| SCHEMBL554655 | 0.67 | MEN1 (0.62) | MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539986-A | Application of composition containing perfluoroether compound as heat transfer medium | 浙江诺亚氟化工有限公司 | 2022-05-27 | — | — | CN | claimed |
| US-8753606-B2 | Multimodal imaging method using nano-emulsion comprising optical nano-particles and perfluorocarbons | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2014-06-17 | — | — | US | claimed |
| US-8734762-B2 | Perfluorocarbon nano-emulsion containing quantum dot nanoparticles and method for preparing the same | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2014-05-27 | — | — | US | claimed |
| US-8697389-B2 | Cell labeling and imaging using multifunctional perfluorocarbon nanoemulsion | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2014-04-15 | — | — | US | claimed |
| US-20120088261-A1 | CELL LABELING AND IMAGING USING MULTIFUNCTIONAL PERFLUOROCARBON NANOEMULSION | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2012-04-12 | — | — | US | claimed |
| US-20110110867-A1 | MULTIMODAL IMAGING METHOD USING NANO-EMULSION COMPRISING OPTICAL NANO-PARTICLES AND PERFLUOROCARBONS | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2011-05-12 | — | — | US | claimed |
| US-20100233094-A1 | PERFLUOROCARBON NANO-EMULSION CONTAINING QUANTUM DOT NANOPARTICLES AND METHOD FOR PREPARING THE SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECH (KR) | 2010-09-16 | — | — | US | claimed |
| WO-2009154425-A9 | MULTIMODAL IMAGING METHOD USING NANO-EMULSION COMPRISING OPTICAL NANO-PARTICLES AND PERFLUOROCARBONS | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2010-03-18 | — | — | WO | claimed |
| WO-2009154425-A2 | MULTIMODAL IMAGING METHOD USING NANO-EMULSION COMPRISING OPTICAL NANO-PARTICLES AND PERFLUOROCARBONS | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2009-12-23 | — | — | WO | claimed |
| WO-2009051337-A1 | PERFLUOROCARBON NANO-EMULSION CONTAINING QUANTUM DOT NANOPARTICLES AND METHOD FOR PREPARING THE SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2009-04-23 | — | — | WO | claimed |
| US-20230172955-A1 | ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF | METANOI THERAPEUTICS INC (US) | 2023-06-08 | — | — | US | disclosed |
| US-20230144385-A1 | ETHANOLAMINE FORMULATION FOR TREATING EPITHELIAL OVARIAN CARCINOMA | METANOI THERAPEUTICS, INC. | 2023-05-11 | — | — | US | disclosed |
| US-11607421-B2 | Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof | METANOI THERAPEUTICS, INC. (US) | 2023-03-21 | — | — | US | disclosed |
| EP-4132490-A1 | ETHANOLAMINE FORMULATION FOR TREATING EPITHELIAL OVARIAN CARCINOMA | Metanoi Therapeutics, Inc. (US) | 2023-02-15 | — | — | EP | disclosed |
| CN-115666542-A | Ethanolamine formulations for the treatment of epithelial ovarian cancer | 梅塔诺伊治疗公司 | 2023-01-31 | — | — | CN | disclosed |
| EP-0257758-B1 | STABLE BIOLOGICALLY ACTIVE FLUOROCHEMICAL EMULSIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-03-10 | — | — | EP | disclosed |
| EP-0257758-A2 | Stable biologically active fluorochemical emulsions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-03-02 | — | — | EP | disclosed |
| US-4325972-A | BLOOD SUBSTITUTE | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1982-04-20 | — | — | US | disclosed |
| US-4024192-A | PHENOL, HEXAFLUORO PROPENE, PHENYL ALKYL ESTHERS | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-05-17 | — | — | US | disclosed |
| US-4024192-A | PHENOL, HEXAFLUORO PROPENE, PHENYL ALKYL ESTHERS | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230144385-A1 | ETHANOLAMINE FORMULATION FOR TREATING EPITHELIAL OVARIAN CARCINOMA | PHOSPHO1, EGLN3, HIF1AN | MEN1 787/4885KMT2A 771/4885TDP1 4400/4885 |
| US-11607421-B2 | Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof | PHOSPHO1, SGMS2, CHKB | MEN1 210/4885KMT2A 823/4885TDP1 4047/4885 |
| US-20230172955-A1 | ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF | PHOSPHO1, SGMS2, CHKB | MEN1 210/4885KMT2A 823/4885TDP1 4047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.